1. Glucocorticoid- and Transplantation-Induced Osteoporosis
- Author
-
Guido Zavatta, Bart L. Clarke, Zavatta, Guido, and Clarke, Bart L
- Subjects
Endocrinology, Diabetes and Metabolism ,Osteoporosis ,030209 endocrinology & metabolism ,Bioinformatics ,03 medical and health sciences ,Glucocorticoid ,0302 clinical medicine ,Endocrinology ,Bone Density ,BMD ,medicine ,Humans ,Corticosteroid ,Glucocorticoids ,business.industry ,Osteoporosi ,medicine.disease ,Treatment ,Transplantation ,Fracture ,030220 oncology & carcinogenesis ,Glucocorticoid-induced osteoporosi ,Transplant-induced osteoporosi ,Secondary osteoporosis ,business ,medicine.drug - Abstract
Glucocorticoid-induced osteoporosis is the most common cause of secondary osteoporosis; nonetheless, it remains an undertreated condition. Transplantation-induced osteoporosis encompasses a broad range of unique pathogenetic features with distinct characteristics dependent on the transplanted organ. Understanding the pathogenesis of bone loss is key to recommending osteoporosis therapy in these patients. This review summarizes recent advances and addresses current issues in these fields.
- Published
- 2021
- Full Text
- View/download PDF